Vivos Therapeutics Inc is a medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VVOS is expected to report earnings to fall 375.61% to -112 cents per share on March 28
Q4'23
Est.
$-1.13
Q4'24
Beat
by $0.77
Q3'24
Beat
by $0.25
Q3'23
Beat
by $1.25
Q2'23
Missed
by $0.01
The last earnings report on March 31 showed earnings per share of 40 cents, beating the estimate of -36 cents. With 23.98K shares outstanding, the current market capitalization sits at 6.43M.